BIOG-B.ST Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:29):

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other...

Stats
Dzisiejszy wolumen	73 345.00
Średni wolumen	118 919
Kapitalizacja rynkowa	11.10B
EPS	SEK0 ( 2024-02-06 )
Następna data zysków	( SEK0.960 ) 2024-05-06
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	31.52
ATR14	SEK0.132 (0.12%)

Wolumen Korelacja

Długi: -0.06 (neutral)

Krótki: 0.98 (very strong)

Signal:(57.294) Expect same movement, but be aware

BioGaia AB (publ) Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioGaia AB (publ) Korelacja - Waluta/Towar

-0.61
( weak negative )

-0.59
( weak negative )

0.00
( neutral )

-0.59
( weak negative )

-0.10
( neutral )

0.68
( moderate )

BioGaia AB (publ) Finanse

Annual	2023
Przychody:	SEK1.30B
Zysk brutto:	SEK950.19M (73.29 %)
EPS:	SEK3.62

FY	2023
Przychody:	SEK1.30B
Zysk brutto:	SEK950.19M (73.29 %)
EPS:	SEK3.62

FY	2022
Przychody:	SEK1.10B
Zysk brutto:	SEK801.93M (72.64 %)
EPS:	SEK3.70

FY	2021
Przychody:	SEK785.11M
Zysk brutto:	SEK582.95M (74.25 %)
EPS:	SEK9.72

Financial Reports:

No articles found.

BioGaia AB (publ)

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylorithe gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Aktualne aktualizacje dla BioGaia AB (publ) [BIOG-B.ST]

Upcoming Earnings Alert